Effect of different γ-subunit isoforms on the regulation of AMPK

Biochem J. 2017 May 9;474(10):1741-1754. doi: 10.1042/BCJ20170046.

Abstract

AMP-activated protein kinase (AMPK) plays a key role in integrating metabolic pathways in response to energy demand. AMPK activation results in a wide range of downstream responses, many of which are associated with improved metabolic outcome, making AMPK an attractive target for the treatment of metabolic diseases. AMPK is a heterotrimeric complex consisting of a catalytic subunit (α) and two regulatory subunits (β and γ). The γ-subunit harbours the nucleotide-binding sites and plays an important role in AMPK regulation in response to cellular energy levels. In mammals, there are three isoforms of the γ-subunit and these respond differently to regulation by nucleotides, but there is limited information regarding their role in activation by small molecules. Here, we determined the effect of different γ-isoforms on AMPK by a direct activator, 991. In cells, 991 led to a greater activation of γ2-containing AMPK complexes compared with either γ1 or γ3. This effect was dependent on the long N-terminal region of the γ2-isoform. We were able to rule out an effect of Ser108 phosphorylation, since mutation of Ser108 to alanine in the β2-isoform had no effect on activation of AMPK by 991 in either γ1- or γ2-complexes. The rate of dephosphorylation of Thr172 was slower for γ2- compared with γ1-complexes, both in the absence and presence of 991. Our studies show that activation of AMPK by 991 depends on the nature of the γ-isoform. This finding may have implications for the design of isoform-selective AMPK activators.

Keywords: AMPK; metabolic regulation; protein–serine–threonine kinases.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / chemistry
  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Allosteric Regulation / drug effects
  • Amino Acid Substitution
  • Aminopyridines / pharmacology
  • Benzimidazoles / pharmacology
  • Benzoates / pharmacology
  • Binding Sites
  • CRISPR-Cas Systems
  • Enzyme Activation / drug effects
  • Enzyme Activators / pharmacology
  • HEK293 Cells
  • Humans
  • Indoles / pharmacology
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / chemistry
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Ligands
  • Mutation
  • Phosphorylation / drug effects
  • Protein Processing, Post-Translational / drug effects
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Threonine / metabolism

Substances

  • 5-((6-chloro-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl)oxy)-2-methylbenzoic acid
  • Aminopyridines
  • Benzimidazoles
  • Benzoates
  • Enzyme Activators
  • Indoles
  • Isoenzymes
  • Ligands
  • PF-249
  • Recombinant Proteins
  • Threonine
  • PRKAG1 protein, human
  • PRKAG2 protein, human
  • PRKAG3 protein, human
  • AMP-Activated Protein Kinases